FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to injectable bioresorbable compositions of biocomposite materials for treating human bone diseases and disorders as: a material able to be biodegradable in the body completely and to be replaced by new bone tissue for the purpose of bone cell regeneration, osteoconductive and osteoinductive biological support frame for bone tissue regeneration, applied in traumatology, orthopaedics, maxillofacial surgery, and neurosurgery. The injectable biocomposite material contains biological hydroxyapatite, calcium hydrophosphate, amino acid arginine, as well as phosphoprotein (casein) recovered from skim milk, and glutaric aldehyde as a hardener.
EFFECT: preparing the bioresorbable material having the biocompatibility and the pronounced osteoconductive and osteoinductive properties.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HARDENED BIOCOMPOSITE FOR BONE DEFECT REPLACEMENT | 2012 |
|
RU2508131C2 |
| BIOCOMPATIBLE BONE-SUBSTITUTING MATERIAL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2494721C1 |
| BIODEGRADABLE MATERIAL FOR BONE TISSUE REPLACEMENT | 2014 |
|
RU2552943C1 |
| BIOACTIVE COMPOSITE MATERIAL FOR BONE DEFECT REPLACEMENT AND METHOD FOR ITS MANUFACTURE | 2016 |
|
RU2617050C1 |
| POROUS MICROSPHERES OF CALCIUM AND MAGNESIUM BIOPHOSPHATE WITH ADJUSTED PARTICLE SIZE FOR BONE TISSUE REGENERATION | 2012 |
|
RU2497548C1 |
| NANOBIOCOMPOSITION FOR BONE DEFECT FILLING AND REGENERATION STIMULATION | 2023 |
|
RU2818675C1 |
| BIORESORABLE BIOLOGICAL MATRIX FOR SUBSTITUTION OF BONE TISSUE DEFECTS AND METHOD OF ITS OBTAINING | 2017 |
|
RU2665962C1 |
| METHOD FOR PRODUCING A COMPOSITE HYDROGEL FORMED IN SITU TO REPLACE OSTEOCHONDRAL DEFECTS | 2021 |
|
RU2804689C2 |
| CEMENT FOR SUBSTITUTING BONY TISSUE | 2003 |
|
RU2236835C1 |
| CEMENT FOR REPLACING OSSEOUS TISSUE | 2003 |
|
RU2236217C1 |
